The Nasdaq suffered its biggest drop in two-and-a-half years on Thursday after another sharp selloff in biotech and momentum names, including Gilead Sciences (GILD.O) and Trip ..
The group justified the near-zero price citing an "information vacuum" over Mt. Gox's missing bitcoins that made it hard to place a value on the lost digital cu ..
Reuters has confirmed that the engineers are Ray DeGiorgio and Gary Altman. Also on Thursday, GM said it will take a higher-than-expected charge of $1.3 billion in the first q ..
The Dow, S&P 500 and Nasdaq all ended the day down sharply. What's behind the dive? ..
SAC Capital Advisors' $1.2 billion criminal settlement for insider trading received final court approval on Thursday, as a U.S. judge accepted a guilty plea from the hedg ..
General Motors Co (GM) on Thursday said it will take a charge of $1.3 billion in the first quarter to cover recall-related repairs and costs, which includes a $750 million cha ..
Some of the most prominent names in biotechnology plunged on Thursday as the Nasdaq headed for its worst day in nearly two years. ..
Some of Wall Street and Silicon Valley’s best minds are packing it all in for greener pastures. And they’ve found those pastures in…trailer parks. ..
Stocks are heading lower after a mixed batch of corporate earnings reports. Biogen Idec, Gilead Sciences and other biotech companies extended their recent slump. ..
Ally also has issues of its own as it faces intensifying competition, analysts said. Ally's offering raised $2.38 billion for the Treasury, giving the government a profit ..